Lindus Health to accelerate clinical trials with £6.5m funding
After receiving £6.5m, Lindus Health is aiming to revolutionise the clinical trials process by speeding up the process with machine learning.
AI and Analytics
InHealth partners with Qure.ai for AI-powered chest x-ray solution
InHealth will be deploying Qure.ai’s chest x-ray solution to improve the accuracy, efficiency and workflow of chest x-rays.
AI and Analytics
Lilli partner with Nourish to deliver data-driven falls prevention
Lilli, a company using machine learning (ML) to revolutionise home care, has announced a partnership with digital care management provider Nourish Care.
AI and Analytics
Pictura Bio receives funding for AI disease testing platform for military use
Pictura Bio has announced that it has been awarded funding to develop a prototype of its AI-powered disease testing platform for use in military settings.
AI and Analytics
Qureight aims to reduce racial inequalities in lung disease treatment
Medical technology company Qureight is working with University Hospitals Birmingham to ensure its AI model for treating IPF reflects a diverse population.
AI and Analytics
Leeds Teaching Hospitals collaborates on AI cancer test
Leeds Teaching Hospitals NHS Trust is collaborating on an AI-powered test that has the potential to speed up the cancer diagnosis process.
AI and Analytics
AdviseInc secures contracts with 22 NHS trusts in four months
AdviseInc has announced it has secured 22 new NHS trust contracts and 61 NHS trust contract renewals since the start of the year.
AI and Analytics
Great Ormond Street and Roche UK partner to improve child care using AI
Great Ormond Street Hospital for Children and Roche UK are co-developing digital tools to better care for children with rare and complex diseases.
AI and Analytics
Roche UK and Nye Health partner to use AI to enhance patients’ lives
Roche UK and Nye Health have partnered to co-create digital solutions that learn and adapt to patients’ needs outside of a traditional clinical setting.
AI and Analytics
Ultromics granted FDA Breakthrough Device Status
Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
AI and Analytics